The Paper Cut

  • May 15FIRST DAY OF 2019 SCHOOL YEAR AUGUST 1ST

  • May 15GRADUATION MAY 23 AT 7PM

  • April 5BEST OF LUCK TO ALL SENIORS - THIS ISSUE FOR YOU!

FDA Approves Nasal Spray That Treats Depression

Azalia Munoz, Senior Spotlight Editor

Hang on for a minute...we're trying to find some more stories you might like.


Email This Story






Distributed by Johnson & Johnson, the first-ever nasal spray that can treat depression, Spravato, has been cleared by the FDA to treat depression, and research that has been conducted shows that the drug can be effective in hours instead of weeks. The results are credited to the use of esketamine, one of the two mirror-image molecules that form ketamine. Ketamine is a medication mainly used for anesthesia – the medication puts the user in a trance-like state while providing pain relief, sedation, and memory loss. The difference between the two is small, seeing as though esketamine is a part of ketamine. This spray is for people who have “treatment-resistant depression,” meaning that a person has to have no effect with two other depression treatments prior to acquiring the spray.

Depression is a problem in the United States, impacting mostly teenagers/young adults. A report found that diagnoses are most prevalent among those under 35 – diagnoses going up by 47%. Even with these reports, most people go untreated + don’t report what they’re going through. Depression is caused by a lack of the chemical, serotonin which is what causes people to feel ‘happy’. Most depression treatments target the chemical serotonin, but Spravato targets glutamate which is why this seems to work more effectively for people who haven’t found success with traditional treatments. During the first month of treatment, patients will either receive a 56mg dose or an 84mg dose twice a week. The cost of Spravato per treatment session will range from $590 – $885, although this all depends on insurance + other factors.

Side effects include disassociation, dizziness, sedation, decreased feeling or sensitivity, anxiety, lethargy, increased blood pressure, vomiting, and feeling drunk.

It will be released March 5th, and a website will be available to purchase + more research will be on the website for potential users to read.

 

 

Print Friendly, PDF & Email
About the Writer
Azalia Munoz, Senior Profile Editor

Azalia is senior at Sahuaro HS who spends most of her life with earbuds in her ear. The Killers, The Neighbourhood, Fleetwood Mac, and The Growlers are...

Leave a Comment

If you want a picture to show with your comment, go get a gravatar.




Navigate Left
  • FDA Approves Nasal Spray That Treats Depression

    Headline News

    2019 SENIOR SHOUTOUTS!!!!

  • FDA Approves Nasal Spray That Treats Depression

    Headline News

    Six Car Crane Crash

  • FDA Approves Nasal Spray That Treats Depression

    Headline News

    Is This Whale a Russian Spy?

  • FDA Approves Nasal Spray That Treats Depression

    Headline News

    Former VP Making A Play for President

  • FDA Approves Nasal Spray That Treats Depression

    Headline News

    Woman Dies Protecting Rabbi During Synagogue Shooting

  • FDA Approves Nasal Spray That Treats Depression

    Headline News

    Columbine School Shooting Obsessed Teen Most Likely Committed Suicide

  • FDA Approves Nasal Spray That Treats Depression

    News You Can Use

    Free Summer Gym Memberships for Teenagers

  • FDA Approves Nasal Spray That Treats Depression

    Headline News

    Is The Ice Age Coming Back??

  • FDA Approves Nasal Spray That Treats Depression

    News You Can Use

    Tips You Haven’t Heard About Surviving School Shootings

  • FDA Approves Nasal Spray That Treats Depression

    Headline News

    First the Snap Map, Now the JUUL Map?

Navigate Right
Delivering Sahuaro's Cutting Edge News & Saving Trees
FDA Approves Nasal Spray That Treats Depression